Purinergic P2 Receptor Antagonists

Known as: Antagonists, P2 Purinoceptor, Purinoceptor Antagonists, P2, Purinergic P2 Receptor Blockers 
Compounds that bind to and block the stimulation of PURINERGIC P2 RECEPTORS.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2017
01219902017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
IL-27 bridges innate and adaptive immunity by modulating cytokine production from myeloid cells and regulating Th cell… (More)
Is this relevant?
2015
2015
Cell stress is implicated in triggering bouts of systemic inflammation in patients with autoinflammatory disorders. Blood… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
Renal ischemic/reperfusion injury in vivo results in a significant increase of acute renal failure (ARF) and death. Nevertheless… (More)
Is this relevant?
2000
2000
ATP is known to act as an extracellular messenger mediating the propagation of Ca(2+) waves in astrocyte networks. ATP mediates… (More)
Is this relevant?
1996
1996
In isolated, constant-pressure perfused rat kidneys at basal vascular tone, injected P2 purinoceptor agonists evoked… (More)
Is this relevant?
1996
1996
Changes in cytosolic free Ca2+ concentration ([Ca2+]i) induced by ATP and other P2 purinoceptor agonists were investigated using… (More)
Is this relevant?
1996
1996
Since the P2X purinoceptor has been shown to be homologous with RP-2, a gene activated in thymocytes undergoing apoptosis after… (More)
Is this relevant?
1995
1995
1. The role of endogenous ADP in platelet aggregation in vivo remains unclear due to the lack of suitable P2T-antagonist probes… (More)
Is this relevant?
1995
1995
In the present study, the novel compound pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS), which has been shown to… (More)
Is this relevant?
1990
1990
3'-O-(4-Benzoyl)benzoyl-ATP (BzATP), a photoaffinity analog of ATP, was used as a ligand for a P2Y purinoceptor (adenine… (More)
Is this relevant?